Forest Announces U.S. Availability of New Once-Daily NAMENDA XR NEW YORK--(BUSINESS WIRE)--Forest Laboratories, Inc. announced today that NAMENDA XR(TM) (memantine hydrochloride) once-daily formulation is now available in pharmacies throughout the United States. NAMENDA XR is approved by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe dementia of the Alzheimer’s type. New NAMENDA XR 28 mg is a higher dose, once-daily ...
June 13, 2013 - Business Wire